These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 3191817

  • 1. Developmental changes of caffeine elimination in infancy.
    Pons G, Carrier O, Richard MO, Rey E, d'Athis P, Moran C, Badoual J, Olive G.
    Dev Pharmacol Ther; 1988; 11(5):258-64. PubMed ID: 3191817
    [Abstract] [Full Text] [Related]

  • 2. Caffeine Citrate Dosing Adjustments to Assure Stable Caffeine Concentrations in Preterm Neonates.
    Koch G, Datta AN, Jost K, Schulzke SM, van den Anker J, Pfister M.
    J Pediatr; 2017 Dec; 191():50-56.e1. PubMed ID: 29173321
    [Abstract] [Full Text] [Related]

  • 3. Caffeine citrate treatment for extremely premature infants with apnea: population pharmacokinetics, absolute bioavailability, and implications for therapeutic drug monitoring.
    Charles BG, Townsend SR, Steer PA, Flenady VJ, Gray PH, Shearman A.
    Ther Drug Monit; 2008 Dec; 30(6):709-16. PubMed ID: 19057373
    [Abstract] [Full Text] [Related]

  • 4. Plasma theophylline and caffeine and plasma clearance of theophylline during theophylline treatment in the first year of life.
    Lönnerholm G, Lindström B, Paalzow L, Sedin G.
    Eur J Clin Pharmacol; 1983 Dec; 24(3):371-4. PubMed ID: 6861850
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of theophylline and caffeine after intravenous administration of aminophylline to premature neonates in Korea.
    Ahn HW, Shin WG, Park KJ, Suh OK, Choi JH.
    Res Commun Mol Pathol Pharmacol; 1999 Dec; 105(1-2):105-13. PubMed ID: 10850374
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetic aspects of caffeine in premature infants with apnoea.
    Gorodischer R, Karplus M.
    Eur J Clin Pharmacol; 1982 Dec; 22(1):47-52. PubMed ID: 7094974
    [Abstract] [Full Text] [Related]

  • 7. Developmental aspects of percutaneous caffeine absorption in premature infants.
    Amato M, Hüppi P, Isenschmid M, Schneider H.
    Am J Perinatol; 1992 Dec; 9(5-6):431-4. PubMed ID: 1418150
    [Abstract] [Full Text] [Related]

  • 8. Population pharmacokinetic study of caffeine citrate in Chinese premature infants with apnea.
    Guo A, Zhu Z, Xue J, Di X, Fan J, Huang L, Zhao P, Hu X, Xie H.
    J Clin Pharm Ther; 2020 Dec; 45(6):1414-1421. PubMed ID: 32737938
    [Abstract] [Full Text] [Related]

  • 9. Maturational changes of caffeine concentrations and disposition in infancy during maintenance therapy for apnea of prematurity: influence of gestational age, hepatic disease, and breast-feeding.
    Le Guennec JC, Billon B, Paré C.
    Pediatrics; 1985 Nov; 76(5):834-40. PubMed ID: 4058995
    [Abstract] [Full Text] [Related]

  • 10. [Clinical effectiveness of different doses of caffeine for primary apnea in preterm infants].
    Zhao Y, Tian X, Liu G.
    Zhonghua Er Ke Za Zhi; 2016 Jan; 54(1):33-6. PubMed ID: 26791921
    [Abstract] [Full Text] [Related]

  • 11. Population pharmacokinetics of intravenous caffeine in neonates with apnea of prematurity.
    Lee TC, Charles B, Steer P, Flenady V, Shearman A.
    Clin Pharmacol Ther; 1997 Jun; 61(6):628-40. PubMed ID: 9209245
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics of doxapram in idiopathic apnea of prematurity.
    Beaudry MA, Bradley JM, Gramlich LM, LeGatt D.
    Dev Pharmacol Ther; 1988 Jun; 11(2):65-72. PubMed ID: 3371147
    [Abstract] [Full Text] [Related]

  • 13. Effect of formula feeding on oral absorption of caffeine in premature infants.
    Giacoia GP, Jungbluth GL, Jusko WJ.
    Dev Pharmacol Ther; 1989 Jun; 12(4):205-10. PubMed ID: 2766923
    [Abstract] [Full Text] [Related]

  • 14. Caffeine citrate therapy for apnea of prematurity.
    Johnson PJ.
    Neonatal Netw; 2011 Jun; 30(6):408-12. PubMed ID: 22052121
    [No Abstract] [Full Text] [Related]

  • 15. Caffeine Therapy in Preterm Infants: The Dose (and Timing) Make the Medicine.
    Rostas SE, McPherson C.
    Neonatal Netw; 2019 Nov 01; 38(6):365-374. PubMed ID: 31712401
    [Abstract] [Full Text] [Related]

  • 16. [Efficacy of percutaneous caffeine in the treatment of apnea in the premature infant].
    Morisot C, Simoens C, Trublin F, Lhermitte M, Gremillet C, Robert MH, Lequien P.
    Arch Fr Pediatr; 1990 Mar 01; 47(3):221-4. PubMed ID: 2344252
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetic profile of caffeine in the premature newborn infant with apnea.
    Aranda JV, Cook CE, Gorman W, Collinge JM, Loughnan PM, Outerbridge EW, Aldridge A, Neims AH.
    J Pediatr; 1979 Apr 01; 94(4):663-8. PubMed ID: 430317
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics, pharmacodynamics and metabolism of caffeine in newborns.
    Aranda JV, Beharry KD.
    Semin Fetal Neonatal Med; 2020 Dec 01; 25(6):101183. PubMed ID: 33293242
    [Abstract] [Full Text] [Related]

  • 19. Effectiveness and side effects of two different doses of caffeine in preventing apnea in premature infants.
    Romagnoli C, De Carolis MP, Muzii U, Zecca E, Tortorolo G, Chiarotti M, De Giovanni N, Carnevale A.
    Ther Drug Monit; 1992 Feb 01; 14(1):14-9. PubMed ID: 1546385
    [Abstract] [Full Text] [Related]

  • 20. [Pharmacokinetics of theophylline and caffeine in premature infants with apnea (author's transl)].
    Riechert M, Lipowsky G, Stöckl H, Stiegler H.
    Monatsschr Kinderheilkd; 1981 Dec 01; 129(12):697-702. PubMed ID: 7329425
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.